News 1/22/25 – HIStalk
Top News
Struggling consumer genetic testing company 23andMe considers selling its Lemonaid telehealth business.
23andMe acquired the business in 2021 for $400 million.
23andMe’s entire board resigned last September over differences in the company’s direction. It announced…